Voyageur Pharmaceuticals Management
Management criteria checks 2/4
Voyageur Pharmaceuticals' CEO is Brent Willis, appointed in Jul 2019, has a tenure of 4.83 years. total yearly compensation is CA$131.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 4.97% of the company’s shares, worth CA$379.73K. The average tenure of the management team and the board of directors is 3.3 years and 1.7 years respectively.
Key information
Brent Willis
Chief executive officer
CA$131.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 4.8yrs |
| CEO ownership | 5.0% |
| Management average tenure | 3.3yrs |
| Board average tenure | 1.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Feb 29 2024 | n/a | n/a | -CA$1m |
| Nov 30 2023 | n/a | n/a | -CA$1m |
| Aug 31 2023 | n/a | n/a | -CA$2m |
| May 31 2023 | n/a | n/a | -CA$2m |
| Feb 28 2023 | n/a | n/a | -CA$2m |
| Nov 30 2022 | CA$131k | CA$131k | -CA$2m |
| Aug 31 2022 | n/a | n/a | -CA$2m |
| May 31 2022 | n/a | n/a | -CA$2m |
| Feb 28 2022 | n/a | n/a | -CA$2m |
| Nov 30 2021 | CA$110k | CA$110k | -CA$2m |
| Aug 31 2021 | n/a | n/a | -CA$2m |
| May 31 2021 | n/a | n/a | -CA$853k |
| Feb 28 2021 | n/a | n/a | -CA$820k |
| Nov 30 2020 | CA$43k | CA$43k | -CA$1m |
| Aug 31 2020 | n/a | n/a | -CA$1m |
| May 31 2020 | n/a | n/a | -CA$999k |
| Feb 29 2020 | n/a | n/a | -CA$817k |
| Nov 30 2019 | CA$63k | CA$63k | -CA$552k |
| Aug 31 2019 | n/a | n/a | -CA$798k |
| May 31 2019 | n/a | n/a | -CA$511k |
| Feb 28 2019 | n/a | n/a | -CA$558k |
| Nov 30 2018 | CA$60k | CA$60k | -CA$556k |
| Aug 31 2018 | n/a | n/a | -CA$359k |
| May 31 2018 | n/a | n/a | -CA$637k |
| Feb 28 2018 | n/a | n/a | -CA$767k |
| Nov 30 2017 | CA$65k | CA$60k | -CA$671k |
Compensation vs Market: Brent's total compensation ($USD96.28K) is below average for companies of similar size in the Canadian market ($USD175.83K).
Compensation vs Earnings: Brent's compensation has increased whilst the company is unprofitable.
CEO
Brent Willis (52 yo)
4.8yrs
Tenure
CA$131,000
Compensation
Mr. Brent Willis, Bsc. Eng., serves as President of Voyageur Pharmaceuticals Ltd. (formerly known as Voyageur Minerals Ltd.) since July 1, 2019 and serves as its Director since October 30, 2017. Mr. Willis...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.8yrs | CA$131.00k | 4.97% CA$ 379.7k | |
| Founder | 9.7yrs | CA$125.50k | 4.88% CA$ 372.8k | |
| Chief Financial Officer | 1.8yrs | CA$32.40k | no data | |
| Sales Manager | less than a year | no data | no data |
3.3yrs
Average Tenure
Experienced Management: VM's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.6yrs | CA$131.00k | 4.97% CA$ 379.7k | |
| Founder | 4.7yrs | CA$125.50k | 4.88% CA$ 372.8k | |
| Director | less than a year | no data | no data | |
| Independent Director | 2.8yrs | CA$38.31k | no data | |
| Independent Director | 1.7yrs | no data | no data | |
| Independent Director | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | less than a year | no data | no data |
1.7yrs
Average Tenure
57.5yo
Average Age
Experienced Board: VM's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.